DNA Testing Kits AI Visibility Ranking Trends - November 2026

Answer capsule

The November 2026 DNA Testing Kits benchmark compares 10 companies across 561 AI answers that met its inclusion rules. AncestryDNA leads with 349 recommendations (62.21% of answers). At least one tracked company was recommended in 362 answers; some answers recommended several companies.

The rankings distinguish being mentioned from receiving an affirmative recommendation, then examine placement and the wording used about each company. Earlier monthly results show how counts and rates changed, with each month using its own answer total. These results describe the answers reviewed, not product quality or customer satisfaction. Differences between monthly samples limit comparisons and do not establish why a result changed.

For the strategic interpretation of this benchmark, read CiteWorks Studio's analysis of How AI Search Is Recommending DNA Testing Kits

Industry leaderboard

Questions This Section Answers

• How do DNA Testing Kits rank by recorded AI recommendations in November 2026?

The leaderboard orders companies by how many answers recorded an affirmative recommendation, so it measures endorsement volume rather than visibility alone. A company can appear often yet be recommended less often, and the two readings answer different questions. Ties reflect equal recommendation counts, not shared placement or framing. Placement figures are nested within recommendations, so first-place and shortlist counts should be read as subsets rather than separate wins.

Key findings

Tracked-company answer coverage

Questions This Section Answers

• How often did the November 2026 DNA Testing Kits answer sample recommend any tracked company?

362 distinct answers recommended at least one tracked company. Counting each company recommendation separately gives 1255, because an answer can recommend several companies. Answers with no tracked recommendation may still have recommended companies outside this comparison.

Coverage describes how many answers touched the tracked set at all. Every qualified answer mentioned at least one tracked company, while a smaller group recommended one, and many answers recommended several companies at once. Because a single answer can name multiple brands, company totals overlap and cannot be summed into a market share. Answers without a tracked recommendation may still have named companies outside this comparison.

Reach and affirmative recommendation

AncestryDNA ranks 1 by recommendation count. Mentions: 560 (99.82%); recommendations: 349 (62.21%). Top 3 placements: 317 (56.51%); first-place placements: 305 (54.37%).

Wording about the company: 369 positive, 188 neutral, 3 negative mentions. The proportion of mentions that also included a recommendation was 62.3%. The net framing score was 0.65 (defined in Methodology).

211 mentions had no recorded recommendation. Of recorded recommendations, 90.83% were Top 3 and 87.39% were first-place.

Reach and recommendation are distinct measurements. AncestryDNA appeared in nearly every answer, but a recommendation was recorded in a smaller portion of those appearances, leaving many mentions without endorsement. The gap between presence and endorsement is the useful signal here: being named is not the same as being affirmatively put forward. Placement counts sit inside the recommendation set, not beside it.

Recommendation order and placement

Placement records where a recommended company sat in the answer's ordering. Top-three and first-place counts are subsets of recommendations, so they cannot be added to recommendation totals or compared as if they shared a separate base. Recommendation-to-mention ratios describe the recorded wording of answers, not customer behavior, sales or conversion. A high ratio on a small base warrants caution.

Classified framing in context

Framing classifies the wording surrounding a mention as positive, neutral or negative. It is not a measure of customer sentiment, reputation or company quality, and neutral wording does not explain why a recommendation was or was not recorded. Most mentions across the tracked set carried positive or neutral wording, with negative wording rare. These classifications describe the selected answers only.

Company results in detail

AncestryDNA

Questions This Section Answers

• What do the November 2026 AI answer results show about AncestryDNA mentions, recommendations and placement?

AncestryDNA ranks 1 by recommendation count. Mentions: 560 (99.82%); recommendations: 349 (62.21%). Top 3 placements: 317 (56.51%); first-place placements: 305 (54.37%).

Wording about the company: 369 positive, 188 neutral, 3 negative mentions. The proportion of mentions that also included a recommendation was 62.3%. The net framing score was 0.65 (defined in Methodology).

211 mentions had no recorded recommendation. Of recorded recommendations, 90.83% were Top 3 and 87.39% were first-place.

From October 2026 to November 2026, AncestryDNA's mention count fell from 561 to 560, while its recommendation count fell from 412 to 349. The recommendation rate was 73.18% and 62.21% respectively.

AncestryDNA leads on recommendation volume and appears in almost every answer, giving it the broadest reach in the tracked set. Its recommendations are overwhelmingly recorded in top-three and first-place positions, so its placement profile is unusually concentrated at the front. Framing is mostly positive with few negative mentions. The month-to-month comparison shows lower counts and a lower recommendation rate than the prior sample, though the samples differ.

23andMe

Questions This Section Answers

• What do the November 2026 AI answer results show about 23andMe mentions, recommendations and placement?

23andMe ranks 2 by recommendation count. Mentions: 544 (96.97%); recommendations: 275 (49.02%). Top 3 placements: 213 (37.97%); first-place placements: 5 (0.89%).

Wording about the company: 296 positive, 239 neutral, 9 negative mentions. The proportion of mentions that also included a recommendation was 50.6%. The net framing score was 0.53 (defined in Methodology).

269 mentions had no recorded recommendation. Of recorded recommendations, 77.45% were Top 3 and 1.82% were first-place.

From October 2026 to November 2026, 23andMe's mention count fell from 547 to 544, while its recommendation count fell from 379 to 275. The recommendation rate was 67.32% and 49.02% respectively.

23andMe holds the second position by recommendation count with near-universal mention reach. Its distinctive feature is placement: recommendations are frequently recorded in the top three but rarely at first place, a much steeper drop than peers show. Framing is largely positive with a small negative share. The prior-month comparison records lower counts and a lower recommendation rate, without establishing why.

MyHeritage DNA

Questions This Section Answers

• What do the November 2026 AI answer results show about MyHeritage DNA mentions, recommendations and placement?

MyHeritage DNA ranks 3 by recommendation count. Mentions: 442 (78.79%); recommendations: 243 (43.32%). Top 3 placements: 177 (31.55%); first-place placements: 9 (1.60%).

Wording about the company: 262 positive, 176 neutral, 4 negative mentions. The proportion of mentions that also included a recommendation was 55.0%. The net framing score was 0.58 (defined in Methodology).

199 mentions had no recorded recommendation. Of recorded recommendations, 72.84% were Top 3 and 3.70% were first-place.

From October 2026 to November 2026, MyHeritage DNA's mention count fell from 449 to 442, while its recommendation count fell from 335 to 243. The recommendation rate was 59.50% and 43.32% respectively.

MyHeritage DNA ranks third on recommendations with strong mention reach. Its recommendations are often placed in the top three, while first-place appearances are comparatively few, so its profile sits between broad shortlisting and front-position strength. Framing skews positive with minimal negative wording. The recorded comparison with the prior sample shows lower counts and a lower recommendation rate.

FamilyTreeDNA

Questions This Section Answers

• What do the November 2026 AI answer results show about FamilyTreeDNA mentions, recommendations and placement?

FamilyTreeDNA ranks 4 by recommendation count. Mentions: 388 (69.16%); recommendations: 205 (36.54%). Top 3 placements: 100 (17.83%); first-place placements: 3 (0.53%).

Wording about the company: 221 positive, 167 neutral, 0 negative mentions. The proportion of mentions that also included a recommendation was 52.8%. The net framing score was 0.57 (defined in Methodology).

183 mentions had no recorded recommendation. Of recorded recommendations, 48.78% were Top 3 and 1.46% were first-place.

From October 2026 to November 2026, FamilyTreeDNA's mention count fell from 426 to 388, while its recommendation count fell from 325 to 205. The recommendation rate was 57.73% and 36.54% respectively.

FamilyTreeDNA ranks fourth by recommendation count with solid mention reach. Its recommendations are recorded in the top three about half the time and at first place rarely, indicating shortlist presence without frequent front placement. Framing is positive or neutral with no negative mentions recorded. The prior-month comparison shows lower counts and a lower recommendation rate across differing samples.

Nebula Genomics

Questions This Section Answers

• What do the November 2026 AI answer results show about Nebula Genomics mentions, recommendations and placement?

Nebula Genomics ranks 5 by recommendation count. Mentions: 154 (27.45%); recommendations: 95 (16.93%). Top 3 placements: 30 (5.35%); first-place placements: 3 (0.53%).

Wording about the company: 102 positive, 52 neutral, 0 negative mentions. The proportion of mentions that also included a recommendation was 61.7%. The net framing score was 0.66 (defined in Methodology).

59 mentions had no recorded recommendation. Of recorded recommendations, 31.58% were Top 3 and 3.16% were first-place.

From October 2026 to November 2026, Nebula Genomics' mention count rose from 126 to 154, while its recommendation count rose from 93 to 95. The recommendation rate was 16.52% and 16.93% respectively.

Nebula Genomics ranks fifth on recommendations with more moderate mention reach. Its recommendation-to-mention ratio is comparatively high, meaning appearances more often carried endorsement, though the base is smaller than the leaders'. Top-three placements are a minority of its recommendations and first-place appearances are rare. Framing is mostly positive. Both counts rose slightly against the prior sample.

Living DNA

Questions This Section Answers

• What do the November 2026 AI answer results show about Living DNA mentions, recommendations and placement?

Living DNA ranks 6 by recommendation count. Mentions: 183 (32.62%); recommendations: 73 (13.01%). Top 3 placements: 9 (1.60%); first-place placements: 1 (0.18%).

Wording about the company: 88 positive, 95 neutral, 0 negative mentions. The proportion of mentions that also included a recommendation was 39.9%. The net framing score was 0.48 (defined in Methodology).

110 mentions had no recorded recommendation. Of recorded recommendations, 12.33% were Top 3 and 1.37% were first-place.

From October 2026 to November 2026, Living DNA's mention count rose from 148 to 183, while its recommendation count fell from 97 to 73. The recommendation rate was 17.23% and 13.01% respectively.

Living DNA ranks sixth by recommendation count, with mention reach exceeding its recommendation share. Its recommendation-to-mention ratio is lower than most peers, and top-three placements are a small fraction of its recommendations. Framing is split between positive and neutral with no negative mentions. Mentions rose while recommendations fell against the prior sample, a mixed recorded movement.

tellmeGen

Questions This Section Answers

• What do the November 2026 AI answer results show about tellmeGen mentions, recommendations and placement?

tellmeGen ranks 7 by recommendation count. Mentions: 22 (3.92%); recommendations: 7 (1.25%). Top 3 placements: 3 (0.53%); first-place placements: 1 (0.18%).

Wording about the company: 8 positive, 14 neutral, 0 negative mentions. The proportion of mentions that also included a recommendation was 31.8%. The net framing score was 0.36 (defined in Methodology).

15 mentions had no recorded recommendation. Of recorded recommendations, 42.86% were Top 3 and 14.29% were first-place.

From October 2026 to November 2026, tellmeGen's mention count rose from 12 to 22, while its recommendation count rose from 3 to 7. The recommendation rate was 0.53% and 1.25% respectively.

tellmeGen ranks seventh with a small mention base and few recommendations. Its recommendation-to-mention ratio is modest, and the placement counts are sparse, so proportions drawn from them should be read cautiously. Framing is mostly neutral with some positive wording. Both mentions and recommendations rose slightly against the prior sample, though the totals remain small.

African Ancestry

Questions This Section Answers

• What do the November 2026 AI answer results show about African Ancestry mentions, recommendations and placement?

African Ancestry ranks 8 by recommendation count. Mentions: 30 (5.35%); recommendations: 4 (0.71%). Top 3 placements: 3 (0.53%); first-place placements: 1 (0.18%).

Wording about the company: 4 positive, 26 neutral, 0 negative mentions. The proportion of mentions that also included a recommendation was 13.3%. The net framing score was 0.13 (defined in Methodology).

26 mentions had no recorded recommendation. Of recorded recommendations, 75.00% were Top 3 and 25.00% were first-place.

From October 2026 to November 2026, African Ancestry's mention count rose from 21 to 30, while its recommendation count fell from 14 to 4. The recommendation rate was 2.49% and 0.71% respectively.

African Ancestry ranks eighth by recommendation count on a small mention base. Its recommendation-to-mention ratio is low, meaning most appearances carried no endorsement, and framing is predominantly neutral. The few recommendations recorded are mostly in top-three positions, but that proportion rests on a very small base and should not be generalized. Mentions rose while recommendations fell against the prior sample.

CRI Genetics

Questions This Section Answers

• What do the November 2026 AI answer results show about CRI Genetics mentions, recommendations and placement?

CRI Genetics ranks 8 by recommendation count. Mentions: 17 (3.03%); recommendations: 4 (0.71%). Top 3 placements: 0 (0.00%); first-place placements: 0 (0.00%).

Wording about the company: 5 positive, 11 neutral, 1 negative mentions. The proportion of mentions that also included a recommendation was 23.5%. The net framing score was 0.24 (defined in Methodology).

13 mentions had no recorded recommendation. Of recorded recommendations, 0.00% were Top 3 and 0.00% were first-place.

From October 2026 to November 2026, CRI Genetics' mention count rose from 13 to 17, while its recommendation count rose from 3 to 4. The recommendation rate was 0.53% and 0.71% respectively.

CRI Genetics shares the eighth rank on a small mention base with few recommendations. Notably, none of its recorded recommendations were placed in the top three or at first place, a distinct placement profile among tracked companies. Framing is mostly neutral with a single negative mention. Both mentions and recommendations rose slightly against the prior sample, though totals remain small.

Health Nucleus

Questions This Section Answers

• What do the November 2026 AI answer results show about Health Nucleus mentions, recommendations and placement?

Health Nucleus ranks 10 by recommendation count. Mentions: 0 (0.00%); recommendations: 0 (0.00%). Top 3 placements: 0 (0.00%); first-place placements: 0 (0.00%).

Wording about the company: 0 positive, 0 neutral, 0 negative mentions. The proportion of mentions that also included a recommendation was Unavailable. The net framing score was Unavailable (defined in Methodology).

0 mentions had no recorded recommendation. Of recorded recommendations, Unavailable were Top 3 and Unavailable were first-place.

From October 2026 to November 2026, Health Nucleus' mention count stayed at 0, while its recommendation count stayed at 0. The recommendation rate was 0.00% and 0.00% respectively.

Health Nucleus recorded no mentions and no recommendations in this sample, so its placement counts are also zero and ratios requiring a nonzero base are undefined rather than missing. This is a measured zero within the tracked answers, not evidence about the company's standing beyond them. The prior-month comparison likewise shows no recorded activity.

Earlier ranking snapshot context

Questions This Section Answers

• How do the available DNA Testing Kits snapshots from July 2026 to November 2026 differ in recommendation coverage and measurement scope?

Only months with verified results are shown. Monthly sample coverage is listed in Methodology.

The monthly snapshots are separate samples of AI answers, each with its own coverage, so counts and rates should be read together rather than as a continuous series. Rank positions are shown alongside counts because a stable rank can coexist with changing totals. Differences between months describe recorded results only; they do not establish why counts or rates moved, and a single prior month cannot support claims of trend or first-ever outcomes.

What the November Rankings Show

These measures answer different questions. Reach asks whether a company appeared at all; recommendation asks whether the answer affirmatively endorsed it; placement asks where an endorsed company sat in the ordering; framing describes the wording around a mention. A company can be highly visible yet less often recommended, or frequently shortlisted yet rarely placed first. Reading the measures together gives a fuller picture than any single count, while none of them establishes why an answer was worded as it was.

Methodology

Questions This Section Answers

• How were the November 2026 DNA Testing Kits AI visibility measures counted, and what do they not establish?

This benchmark has partial coverage: 3 of 3 planned question categories contributed usable observations; 0 contributed none. This describes question-category coverage, not demonstrated platform outages. Findings apply to the available answer set.

The month in the title is the reporting period. The exact dates when the original AI answers were collected have not been verified.

Each company is counted at most once in each answer that meets the benchmark rules. A recommendation requires both an affirmative endorsement and positive wording. Mention, recommendation, Top 3 and first-place rates use the full benchmark answer total. Top 3 and first-place results are included within recommendations, not added to them.

The recommendation-to-mention ratio divides recommendations by mentions. It describes AI answer wording, not customer conversion. Net framing is positive minus negative mentions, divided by all mentions, on a scale from -1 to +1. It does not measure customer satisfaction or company quality.

Market: US; 10 tracked companies. AI services represented: ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity.

Research screening totals (answer observations can include repeated questions):

The source does not provide a reader-facing definition of “reserved”; that screening label is reported without inferring a reason for exclusion. Only the included benchmark answers form the rate denominator.

One answer can mention or recommend several companies. Adding company totals would therefore count some answers more than once. The results describe the AI answers reviewed, not independently verified facts about the companies or their products.

Monthly sample coverage:

The answer samples differ between months. These comparisons show how the recorded results changed; they do not establish why they changed.

Findings apply to the available answer set, which has partial question-category coverage and unverified collection dates. Each company is counted at most once per qualifying answer, and one answer may name several companies, so company totals overlap. Recommendation requires both affirmative endorsement and positive wording. Top-three and first-place results are nested within recommendations. Ratios and framing scores describe answer wording, not customers, sales or company quality, and monthly samples differ, so comparisons show recorded change without explaining it.